(VIANEWS) – Astrazeneca (AZN), Simpson Manufacturing Company (SSD), Fresenius Medical Care AG (FMS) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Astrazeneca (AZN)

43% sales growth and 25.67% return on equity

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.

Astrazeneca’s sales growth this year is expected to be 35.1% and 15.7% for next year.

Year-on-year quarterly revenue growth grew by 31%, now sitting on 29.53B for the twelve trailing months.

Volume

Today’s last reported volume for Astrazeneca is 5669330 which is 25.39% above its average volume of 4521140.

Astrazeneca’s sales growth for the next quarter is 43%. The company’s growth estimates for the current quarter and the next is 40.4% and 45.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.67%.

Volatility

Astrazeneca’s last day, last week, and last month’s current intraday variation average was 1.29%, 0.65%, and 0.71%, respectively.

Astrazeneca’s highest amplitude of average volatility was 2.57% (day), 1.44% (last week), and 1.28% (last month), respectively.

Astrazeneca’s Stock Yearly Top and Bottom Value

Astrazeneca’s stock is valued at $58.85 at 00:22 EST, below its 52-week high of $64.21 and way higher than its 52-week low of $46.48.

Astrazeneca’s Moving Average

Astrazeneca’s value is under its 50-day moving average of $61.00 and higher than its 200-day moving average of $58.24.

2. Simpson Manufacturing Company (SSD)

27.7% sales growth and 22.17% return on equity

Simpson Manufacturing Co., Inc., through its subsidiaries, designs, engineers, manufactures, and sells wood and concrete building construction products.

Simpson Manufacturing Company’s sales growth this year is anticipated to be 24.8% and 12.9% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 1.42B for the twelve trailing months.

Volume

Today’s last reported volume for Simpson Manufacturing Company is 66957 which is 61.87% below its average volume of 175614.

Simpson Manufacturing Company’s sales growth for the next quarter is 27.7%. The company’s growth estimates for the current quarter and the next is 15.6% and 36.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.17%.

Volatility

Simpson Manufacturing Company’s last day, last week, and last month’s current intraday variation average was 0.85%, 0.95%, and 1.28%, respectively.

Simpson Manufacturing Company’s highest amplitude of average volatility was 1.49% (day), 1.84% (last week), and 2.26% (last month), respectively.

Simpson Manufacturing Company’s Stock Yearly Top and Bottom Value

Simpson Manufacturing Company’s stock is valued at $134.27 at 00:22 EST, under its 52-week high of $141.26 and way higher than its 52-week low of $91.25.

Simpson Manufacturing Company’s Moving Average

Simpson Manufacturing Company’s value is above its 50-day moving average of $122.87 and way higher than its 200-day moving average of $113.44.

3. Fresenius Medical Care AG (FMS)

27.6% sales growth and 9.51% return on equity

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally.

Fresenius Medical Care AG’s sales growth this year is expected to be 19.2% and 4.6% for next year.

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 672277 which is 74.62% above its average volume of 384982.

Fresenius Medical Care AG’s sales growth for the next quarter is 27.6%. The company’s growth estimates for the ongoing quarter and the next is a negative 26% and negative -24.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.51%.

Volatility

Fresenius Medical Care AG’s last day, last week, and last month’s current intraday variation average was 2.42%, 1.26%, and 1.17%, respectively.

Fresenius Medical Care AG’s highest amplitude of average volatility was 2.09% (day), 1.53% (last week), and 1.42% (last month), respectively.

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $33.80 at 00:22 EST, way below its 52-week high of $43.33 and way above its 52-week low of $29.71.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s value is higher than its 50-day moving average of $33.36 and way below its 200-day moving average of $37.59.

4. DexCom (DXCM)

19.5% sales growth and 31.66% return on equity

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

DexCom’s sales growth this year is expected to be 24.3% and 21.8% for next year.

Year-on-year quarterly revenue growth grew by 31.7%, now sitting on 2.17B for the twelve trailing months.

Volume

Today’s last reported volume for DexCom is 1400710 which is 87.2% above its average volume of 748214.

DexCom’s sales growth is a negative 0% for the ongoing quarter and 19.5% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 33% and negative -15.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.66%.

Volatility

DexCom’s last day, last week, and last month’s current intraday variation average was 1.89%, 3.49%, and 2.65%, respectively.

DexCom’s highest amplitude of average volatility was 6.32% (day), 5.63% (last week), and 3.99% (last month), respectively.

DexCom’s Stock Yearly Top and Bottom Value

DexCom’s stock is valued at $447.34 at 00:22 EST, way below its 52-week high of $659.45 and way higher than its 52-week low of $318.45.

DexCom’s Moving Average

DexCom’s worth is way below its 50-day moving average of $583.08 and below its 200-day moving average of $471.41.

5. RLI Corp. (RLI)

13.3% sales growth and 24.51% return on equity

RLI Corp., an insurance holding company, underwrites property and casualty insurance in the United States and internationally.

RLI Corp.’s sales growth this year is expected to be 17.4% and 8.6% for next year.

Year-on-year quarterly revenue growth declined by 0.1%, now sitting on 1.15B for the twelve trailing months.

Volume

Today’s last reported volume for RLI Corp. is 16298 which is 85.73% below its average volume of 114269.

RLI Corp.’s sales growth is a negative 0% for the ongoing quarter and 13.3% for the next. The company’s growth estimates for the current quarter and the next is 61.9% and 5.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.51%.

Volatility

RLI Corp.’s last day, last week, and last month’s current intraday variation average was 0.18%, 0.57%, and 1.01%, respectively.

RLI Corp.’s highest amplitude of average volatility was 0.67% (day), 1.31% (last week), and 2.15% (last month), respectively.

RLI Corp.’s Stock Yearly Top and Bottom Value

RLI Corp.’s stock is valued at $109.21 at 00:22 EST, under its 52-week high of $117.84 and way higher than its 52-week low of $95.53.

RLI Corp.’s Moving Average

RLI Corp.’s worth is under its 50-day moving average of $109.86 and higher than its 200-day moving average of $107.95.

6. Hostess Brands (TWNK)

8.8% sales growth and 4.99% return on equity

Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes fresh sweet baked goods in the United States.

Hostess Brands’s sales growth this year is expected to be 10.3% and 5.1% for next year.

Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 1.1B for the twelve trailing months.

Volume

Today’s last reported volume for Hostess Brands is 987477 which is 44.71% below its average volume of 1786160.

Hostess Brands’s sales growth for the next quarter is 8.8%. The company’s growth estimates for the ongoing quarter and the next is 9.5% and 5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.99%.

Volatility

Hostess Brands’s last day, last week, and last month’s current intraday variation average was 1.34%, 0.75%, and 1.28%, respectively.

Hostess Brands’s highest amplitude of average volatility was 5.30% (day), 2.69% (last week), and 2.67% (last month), respectively.

Hostess Brands’s Stock Yearly Top and Bottom Value

Hostess Brands’s stock is valued at $20.46 at 00:22 EST, below its 52-week high of $20.48 and way higher than its 52-week low of $13.66.

Hostess Brands’s Moving Average

Hostess Brands’s value is way higher than its 50-day moving average of $18.58 and way above its 200-day moving average of $16.62.

7. Zebra Technologies (ZBRA)

7.8% sales growth and 35.6% return on equity

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide.

Zebra Technologies’s sales growth this year is expected to be 24.5% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 26.9%, now sitting on 5.47B for the twelve trailing months.

Volume

Today’s last reported volume for Zebra Technologies is 403387 which is 49.37% above its average volume of 270057.

Zebra Technologies’s sales growth for the next quarter is 7.8%. The company’s growth estimates for the current quarter and the next is 24.2% and negative -6.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.6%.

Volatility

Zebra Technologies’s last day, last week, and last month’s current intraday variation average was 0.42%, 0.86%, and 1.19%, respectively.

Zebra Technologies’s highest amplitude of average volatility was 3.86% (day), 3.44% (last week), and 2.56% (last month), respectively.

Zebra Technologies’s Stock Yearly Top and Bottom Value

Zebra Technologies’s stock is valued at $528.00 at 00:22 EST, way below its 52-week high of $615.00 and way higher than its 52-week low of $363.00.

Zebra Technologies’s Moving Average

Zebra Technologies’s value is under its 50-day moving average of $562.85 and under its 200-day moving average of $531.45.

Previous days news about Zebra Technologies(ZBRA)

  • According to Bloomberg Quint on Wednesday, 12 January, "The walkie-talkie app is generally available today and will work with Apple iOS devices and barcode scanners from Zebra Technologies used by many retailers. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here